These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1003646)

  • 1. Primary transitional cell carcinoma of the prostate.
    Greene LF; O'Dea MJ; Dockerty MB
    J Urol; 1976 Dec; 116(6):761-3. PubMed ID: 1003646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis and treatment of prostatic carcinoma].
    Klug W
    Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer of the prostate and other prostatic problems.
    Derrick FC
    Postgrad Med; 1973 Oct; 54(4):123-6. PubMed ID: 4125730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 5. Audit and its impact in the management of advanced prostatic cancer.
    Rana A; Chisholm GD; Christodoulou S; McIntyre M; Elton RA
    Br J Urol; 1993 Oct; 72(4):478-83. PubMed ID: 8261306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
    Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
    Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary transitional cell carcinoma of the prostate.
    Greene LF; Mulcahy JJ; Warren MM; Dockerty MB
    J Urol; 1973 Aug; 110(2):235-7. PubMed ID: 4722621
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of transitional cell carcinoma in the prostate.
    Wolfe JH; Lloyd-Davies RW
    Br J Urol; 1981 Jun; 53(3):253-7. PubMed ID: 7248704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor markers in prostate cancer.
    Cooper EH; Robinson MR; Whelan P; Ferro MA
    Cancer; 1992 Jul; 70(1 Suppl):225-9. PubMed ID: 1376192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periurethral prostatic duct carcinoma: clinical features and treatment results.
    Kopelson G; Harisiadis L; Romas NA; Veenema RJ; Tannenbaum M
    Cancer; 1978 Dec; 42(6):2894-902. PubMed ID: 728880
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
    Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
    J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma of the prostate: a review. I. Incidence, etiology, pathology, and diagnosis.
    Blackard CE
    J Lancet; 1967 Dec; 87(12):477-84 contd. PubMed ID: 4866874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate].
    Mottola A; Di Cello V; Lunghi F; Saltutti C; Natali A; Bianchi S
    Minerva Urol Nefrol; 1991; 43(1):37-9. PubMed ID: 2057864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T; Varkarakis MJ; Murphy GP
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-morphological characteristics of transitional cell carcinoma of the prostate].
    Samsonov VA
    Vopr Onkol; 1985; 31(4):66-70. PubMed ID: 4002672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic adenocarcinoma of ductal origin.
    Greene LF; Farrow GM; Ravits JM; Tomera FM
    J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.